Image Credit: satura86/123rf.com A new breakthrough in gene therapy has shown promising results for children and adults with congenital deafness caused by mutations in the OTOF gene. Researchers from Karolinska Institutet and hospitals across China reported in the journal *Nature Medicine* that a single injection of a synthetic adeno-associated virus (AAV) delivering a functional copy…
Image Credit: By Photo Credit:Content Providers: CDC/Dr. Myron G. Schultz Acoziborole, a groundbreaking new treatment for sleeping sickness, has received approval from the European Medicines Agency, marking a significant advancement in the fight against this life-threatening disease. This innovative drug is the first to offer a single-dose treatment, consisting of three pills taken together, and…
Image Credit: eraxion/123rf.com A research team from the University of Waterloo is pioneering a novel cancer treatment strategy that utilizes engineered bacteria to target and eliminate solid tumors from the inside out. This innovative approach centers on the bacterium Clostridium sporogenes, which thrives in oxygen-deprived environments often found at the core of malignant tumors. Solid…
Image Credit: dolgachov/123rf.com A groundbreaking medical advancement has been achieved as a 42-year-old man with type 1 diabetes became the first person to produce insulin independently after receiving a transplant of genetically edited pancreatic islet cells. This innovative procedure was conducted without the use of immunosuppressant drugs, marking a significant step forward in the treatment…
Image Credit: antonytrivet/123rf.com For the first time, a malaria treatment specifically formulated for newborns has received approval from Swissmedic, Switzerland’s drug regulatory authority. The new medication, named Coartem Baby, is designed for infants weighing less than five kilograms, addressing a significant gap in malaria care for the most vulnerable population. Developed by pharmaceutical company Novartis,…
Image Credit: yourapechkin/123rf.com Researchers at the University of Texas at Dallas have developed a groundbreaking therapy that may significantly improve treatment outcomes for individuals suffering from post-traumatic stress disorder (PTSD). The innovative approach combines vagus nerve stimulation (VNS) with prolonged exposure therapy (PET), showing promising results in a recent small-scale clinical trial. The therapy employs…
Image Credit: janniwet/Shutterstock.com Researchers at the University of Texas Southwestern (UT Southwestern) Medical Center have achieved significant progress in the treatment of neurodegenerative disorders, including Multiple Sclerosis (MS) and Parkinson’s disease (PD), using a novel therapy involving CNM-Au8, a concentrated solution of gold nanocrystals. Central to this advancement is the restoration of the NAD+/NADH ratio,…
